Phage therapy (Adaptive Phage Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePhage therapy (Adaptive Phage Therapeutics)

Drug Alias NameSARS-CoV-2 vaccines (Adaptive Phage Therapeutics)bacteriophage-based SARS-CoV-2 vaccines (Adaptive Phage Therapeutics)bacteriophage-based COVID-19 vaccines (Adaptive Phage Therapeutics)

ClassificationVaccines > Application > Therapeutic vaccineBiologics > Bacteriophages

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdaptive Phage Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdaptive Phage Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A